R. Ortega

发表

Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness

F. Climent, M. Esteller, J. Serra-Musach, 2015, PloS one.

Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?

I. Catalá, A. Petit, T. Soler, 2020, Breast Cancer Research and Treatment.

The effect of omitting axillary dissection and the impact of radiotherapy on patients with breast cancer sentinel node macrometastases: a cohort study following the ACOSOG Z0011 and AMAROS trials

A. Petit, T. Soler, J. Ponce, 2021, Breast Cancer Research and Treatment.

The Shift From Sentinel Lymph Node Biopsy Performed Either Before or After Neoadjuvant Systemic Therapy in the Clinical Negative Nodes of Breast Cancer Patients. Results, and the Advantages and Disadvantages of Both Procedures

T. Soler, J. Ponce, A. García-Tejedor, 2017, Clinical breast cancer.

Feasibility, accuracy and prognosis of sentinel lymph node biopsy before neoadjuvant therapy in breast cancer. A prospective study.

A. Petit, T. Soler, M. Gil-Gil, 2017, International journal of surgery.

Study of breast cancer incidence in patients of lymphangioleiomyomatosis

F. Climent, M. Esteller, M. Pujana, 2016, Breast Cancer Research and Treatment.

Management of the axilla in postmenopausal patients with cN0 hormone receptor-positive/HER2-negative breast cancer treated with neoadjuvant endocrine therapy and its prognostic impact

A. Petit, M. Gil-Gil, J. Ponce, 2023, Breast Cancer Research and Treatment.

Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial)

A. Petit, M. Gil-Gil, J. Ponce, 2023, Frontiers in oncology.

Assessment of Tumor Cell Death After Percutaneous Ultrasound– Guided Radiofrequency Ablation of Breast Carcinoma: A Prospective Study

A. Petit, T. Soler, F. Burdío, 2021, Archives of Breast Cancer.